1. Canada Stocks

  2. •

    Industrials

  3. •

    Specialty Business Services
NexgenRx Inc.

NexgenRx Inc.

NXG.V
NexgenRx Inc.CA flagToronto Stock Exchange Ventures
0.59
CAD
-0.01
- -
41.96MMarket Cap
2013 Y
2014 Y
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
TTM
Revenue per Share
0.09
0.08
0.08
0.1
0.09
0.11
0.14
0.16
0.17
0.18
0.2
0.23
0.25
0.26
Basic EPS, GAAP
0.01
-0.01
- -
0.01
-0.01
-0.01
- -
0.03
0.06
- -
-0.01
0.01
0.01
0.04
Free Cash Flow per Basic Share
0.01
-0.01
- -
0.01
-0.01
-0.01
- -
0.02
0.03
0.01
0.01
0.01
0.07
0.04
Dividend per Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
0.01
0.01
0.01
0.02
0.02
Book Value per Share
- -
-0.01
- -
0.01
0.03
0.03
0.03
0.06
0.11
0.1
0.09
0.08
0.08
0.11
Tangible Book Value per Share
- -
-0.01
- -
0.01
0.02
-0.05
-0.06
-0.03
0.02
0.03
0.02
0.03
0.05
0.08
Basic Weighted Avg Shares
56
56
57
59
60
68
70
70
70
70
71
71
71
74
Sales/Revenue/Turnover
5
4
5
6
6
7
10
11
12
13
14
16
18
19
Operating Margin (%)
14.56
-9.05
-6.99
8.98
-9.34
-7.78
0.98
19.55
18.57
2.25
-1.04
7.27
12.45
18.85
Depreciation Expense
- -
- -
- -
- -
- -
- -
1
1
1
1
1
1
1
1
Net Income, GAAP
1
- -
- -
1
-1
-1
- -
2
4
- -
- -
1
1
3
Effective Tax Rate (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
116.66
- -
40.14
33.37
19.71
Profit Margin (%)
12.39
-11.33
-4.01
10.21
-11.04
-9.72
-2.18
19.16
33.93
-0.18
-2.4
3.73
7.19
13.7
Working Capital
- -
- -
- -
- -
1
-1
-3
-1
1
1
1
2
4
6
LT Debt
- -
- -
- -
- -
- -
1
1
- -
- -
- -
- -
- -
- -
- -
Total Equity
- -
- -
- -
1
2
2
2
6
10
9
8
8
8
9
Return on Invested Capital (%)
267.29
- -
- -
- -
- -
- -
- -
- -
- -
-0.49
- -
8.77
18.43
31.93
Return on Capital (%)
239.55
- -
- -
- -
- -
- -
- -
- -
- -
-0.27
- -
7.75
16.2
29.11
Return on Common Equity (%)
- -
- -
- -
- -
-46.02
-35.56
-10.95
72.8
66.78
-0.29
-7.99
6.92
17.73
37.11

Capital Structure

FRC

•

in mil. unless spec.
Dec'25
Mar'26
Jun'26
ST Debt
- -
- -
- -
LT Borrowings
- -
- -
- -
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
2
2
2
Shares Outstanding
71
71
71
Market Capitalization
28
23
33

Working Capital

FRC

•

in mil. unless spec.
Dec'25
Mar'26
Jun'26
Total Current Assets
32
37
42
Cash, Cash Equivalents & STI
5
5
4
Accounts Receivable, Net
1
1
3
Inventories
- -
- -
- -
Total Current Liabilities
29
32
36
Payables & Accruals
2
1
2
ST Debt
- -
- -
- -
Deferred Revenue
- -
- -
- -

Growth Rates

FRC

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
-59.76%
10.6%
-0.04%
Free Cash Flow
140.85%
99.94%
456.24%
Net Income, GAAP
-59.89%
239.2%
109.86%
Sales/Revenue/Turnover
14.78%
10.27%
8.84%
Total Cash Common Dividend
- -
144.45%
50.21%

Quarterly Revenue

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
4
4
4
4
16
2025
4
4
5
4
18
2026
5
5
- -
- -
- -

Quarterly Earnings Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
0.01
- -
- -
- -
0.01
2025
0.01
- -
0.01
- -
0.01
2026
0.02
0.01
- -
- -
- -

Quarterly Dividends Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
0.01
- -
- -
0.01
2025
- -
0.01
0.01
- -
0.02
2026
- -
0.01
- -
- -
- -

Company Description

Company Profile APIChatGPT
CEO
Ronald C. Loucks
Sector
Industrials
Industry
Specialty Business Services
Address
191 The West Mall Toronto ON Canada M9C 5K8
IPO Date
Sep 15, 2006
Website
nexgenrx.com
Similar Companies
Paraca Inc. (4809.T)
Elvictor Group, Inc. (ELVG)
Balmer Lawrie Investments Limited (BLIL.BO)
Voyager Digital Ltd. (VYGVQ)
Sugimura Warehouse Co., Ltd. (9307.T)
Top KingWin Ltd. Class A (DPU)
Business
NexgenRx Inc. provides third-party administration and software-as-a-service technology solutions for group health-benefit, pension and patient-support programs in Canada. The Company administers, adjudicates and pays prescription drug, dental and extended-health claims on behalf of beneficiaries of health benefit plans sponsored or underwritten by plan sponsors, insurers and other customers. Its principal offerings include NexSys, a rules-based, integrated platform for secure real-time eligibility, enrolment and adjudication of drug, dental and extended-health claims, with front-end, hour-bank, mobile-access and provider-network capabilities; NexAdmin, a benefit-plan administration and self-administration platform that enables sponsors to maintain member information and administer plan operations; NexPension, a multi-employer pension-administration solution for recording and calculating member-group contributions; and NexPSPAssist, a service and claims-adjudication capability designed to help patient support programs optimize delivery for pharmaceutical-manufacturer clients. NexgenRx also provides proprietary claims-processing software, plan-management, enrolment, eligibility, reporting, implementation, operational and related ancillary services. The Company serves plan sponsors, insurers, benefits consultants, insurance brokerages, pharmacy patient-assistance programs, providers, multi-employer union trusts and pharmaceutical companies. NexgenRx began operations in 2003 and is headquartered in Toronto, Ontario. Recent initiatives include continued expansion of client relationships and transaction volumes, investment in digital transformation and process automation, enhancement of its technology platform, and evaluation of practical artificial-intelligence applications through its AI Committee to improve analytics, productivity, customer experience and operating scalability. In August 2026, the Company reported second-quarter revenue growth of 20.8% year over year to C$5.16 million, attributed primarily to higher transaction-fee revenue and continued business expansion, and declared a C$0.005-per-share dividend payable by August 31, 2026.